Machine generated contents note: pt. 1 General Issues -- 1.What to do about abnormal laboratory results -- 2.Abnormal laboratory results -- 3.What does the reference range of a biochemical screen test mean? -- 4.Pitfalls in interpreting laboratory results -- 5.Moving beyond sensitivity and specificity: Using likelihood ratios to help interpret diagnostic tests -- 6.Point-of-care testing comes of age in Australia -- 7.Urine testing -- pt. 2 Biochemistry Tests -- 8.Plasma sodium -- 9.Serum potassium -- 10.Serum urea -- 11.Assessing renal function -- 12.Interpreting arterial blood gases -- 13.Calcium and vitamin D -- 14.Magnesium: The forgotten electrolyte -- 15.Hyperuricaemia -- 16.Liver function tests -- 17.Interpretation and significance of a high blood cholesterol -- 18.Managing hyperlipidaemia: Criteria for investigating lipids -- 19.New cardiac markers -- 20.B-type natriuretic peptide: A new diagnostic tool for congestive heart failure -- 21.Thyroid function tests -- 22.Evaluating adrenocortical function in adults -- 23.The glucose tolerance test -- 24.Diabetes monitoring: Use of glycated haemoglobin and glycated protein assays -- 25.Fertility testing -- 26.Biochemical tests in pregnancy -- 27.Biochemical tests for abnormalities in pregnancy -- 28.Interpreting paediatric biochemistry results -- 29.Drug screens -- 30.Therapeutic drug monitoring: Which drugs, why, when and how to do it -- pt. 3 Haematology Tests -- 31.The red cells -- 32.Interpreting biochemical tests for iron deficiency: Diagnostic difficulties imposed by the limitations of individual tests -- 33.Appropriate use of tests for folate and vitamin B12 deficiency -- 34.Screening for thalassaemia and haemoglobin variants -- 35.Investigations for thrombotic tendencies -- 36.Tests of haemostasis: Detecting the patient at risk of bleeding -- 37.Abnormal haematology results in children -- pt. 4 Microbiology Tests -- 38.Hepatitis B: Laboratory diagnosis and vaccination -- 39.Hepatitis C: Laboratory diagnosis and monitoring -- 40.HIV testing in Australia -- 41.Testing for sexually transmitted infections -- 42.Testing for Helicobacter pylori -- pt. 5 Immunology Tests -- 43.Screening for multiple myeloma -- 44.Testing cell-mediated immunity -- 45.Cell markers -- 46.Skin prick testing and in vitro assays for allergic sensitivity -- 47.Antinuclear antibodies (ANA) -- 48.Rheumatoid factor and anti-citrullinated peptide antibody -- pt. 6 Genetic Tests -- 49.BRCA testing for familial breast cancer.
